Röttinger E M
Klin Padiatr. 1987 May-Jun;199(3):193-5. doi: 10.1055/s-2008-1026788.
The extension of the irradiated treatment volume beyond the primary site has produced permanent control in the majority of patients with medulloblastoma. Available technical procedures are described to reduce or prevent side effects and complications. The complexity of high precision radiotherapy, however, requires stringent quality control, particularly if the effectiveness of additional treatment modalities are examined.
放射治疗范围超出原发部位，已使大多数髓母细胞瘤患者实现了永久性控制。文中描述了可减少或预防副作用及并发症的现有技术程序。然而，高精度放射治疗的复杂性需要严格的质量控制，尤其是在检查其他治疗方式的有效性时。
